Evidence map›Paper›PMID 30595666›Full record

ArticleMediators of inflammation2018

Anti-TNF-

Cui Zhang, Weigang Shu, Guangxi Zhou, Jian Lin, Feifei Chu, Huili Wu, Zhanju Liu

Abstract read
In one paragraph

Article in Mediators of inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Biocompatible Copolymerized Gold Nanoclusters: Anti-Biomimetics (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn's Disease.International journal of molecular sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cui ZhangDepartment of Gastroenterology, The Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Weigang ShuDepartment of Gastroenterology, The Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Guangxi ZhouDepartment of Gastroenterology, The Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Jian LinDepartment of Gastroenterology, The Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Feifei ChuDepartment of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan Province 450007, China.
Huili WuDepartment of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan Province 450007, China.ORCID 0000-0001-9809-7266
Zhanju LiuDepartment of Gastroenterology, The Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.ORCID 0000-0002-0326-543X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils have been found to play an important role in the pathogenesis of inflammatory bowel disease (IBD), and anti-TNF-

Indexed as

AdultAgedEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansInflammatory Bowel DiseasesInfliximabIntestinal MucosaMaleMiddle AgedNeutrophilsTumor Necrosis Factor-alphaInfliximabTumor Necrosis Factor-alpha

Identifiers

PMID30595666
PMCPMC6282128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.